AstraZeneca Says DOJ Closing Probe Into Brilinta Trial

AstraZeneca Says DOJ Closing Probe Into Brilinta Trial

UK pharmaceutical giant AstraZeneca PLC said on Tuesday that it had received confirmation from the U.S. Department of Justice that it is closing its investigation into a clinical trial for the company’s heart drug Brilinta. ...read more

  • Tags: